Diary - News
All news Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth
Saint-Priest (France), September 4, 2018, 8:00 a.m. (CET) – Biom’up (the "Company"), a specialist in surgical hemostasis, today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director. Dr. Byloos’ international experience in the healthcare and medical equipment sectors, combined with his knowledge of the US market will contribute additional support to Biom’up’s management team as the commercial roll-out of its lead product, HEMOBLASTTM Bellows, hits North America.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree